Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  Puretech Health PLC    PRTC   GB00BY2Z0H74

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Summary
  • In view of fundamental criteria, the company is among low performers as far as mid or long-term investment strategy is concerned.
  • The company has poor fundamentals for a short-term investment strategy.
Strengths
  • Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
  • Over the last twelve months, the sales forecast has been frequently revised upwards.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
  • The stock is currently in contact with a medium-term resistance that must be gotten rid of so as to resume the upward trend.
  • According to Thomson-Reuters' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
  • Low profitability weakens the company.
  • The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
  • Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
  • The company's "enterprise value to sales" ratio is among the highest in the world.
Ratings chart
Subsector Biotechnology & Medical Research - NEC
1st jan.Capitalisation (M$)Investor Rating
PURETECH HEALTH PLC13.89%410
INCYTE CORPORATION26.03%25 577
QUINTILES IMS HOLDINGS INC20.36%20 048
LONZA GROUP40.35%17 923
CELLTRION, INC.--.--%11 720
ALKERMES PLC-7.12%7 923
ALNYLAM PHARMACEUTICALS, IN..112.71%7 463
QIAGEN NV8.15%7 264
SEATTLE GENETICS, INC.-11.26%6 747
IONIS PHARMACEUTICALS INC-2.72%5 896
UNITED THERAPEUTICS CORPORA..-9.53%5 736
Autres valeurs du secteur
Company
Engages in the development of treatment programs for obesity, cognitive disorders, baldness, depression, allergy and autoimmunePureTech Health Plc is a cross-disciplinary biopharmacy company, which engages in the development of treatment programs for obesity, cognitive disorders, baldness,... 
Financials ($)
Sales 2017 1,85 M
EBIT 2017 -100 M
Net income 2017 -66,8 M
Finance 2017 41,1 M
Yield 2017 -
P/E ratio 2017 -
P/E ratio 2018
EV / Sales 2017 199x
EV / Sales 2018 208x
Capitalization 410 M
Chart PURETECH HEALTH PLC
Duration : Period : Day
Puretech Health PLC Technical Analysis Chart | PRTC | GB00BY2Z0H74 | 4-Traders
Duration : Period : Week
Puretech Health PLC Technical Analysis Chart | PRTC | GB00BY2Z0H74 | 4-Traders
Surperformance© ratings
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio -
Potential
Yield -
Consensus
7 days EPS revision -
4 months EPS revision -
1 year EPS revision -
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes